palladium has been researched along with bms-911543 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bakrania, L; Beutner, GL; Cohen, B; Cuniere, NL; Eastgate, MD; Fanfair, D; Fox, RJ; Hay, M; Hsiao, Y; Lawler, M; Lobben, P; Markwalter, CE; Regens, C; Rosner, T; Skliar, D; Soumeillant, MC; Strotman, NA; Tran, K; Wei, C; Zhu, K | 1 |
1 other study(ies) available for palladium and bms-911543
| Article | Year |
|---|---|
C-H Arylation in the Formation of a Complex Pyrrolopyridine, the Commercial Synthesis of the Potent JAK2 Inhibitor, BMS-911543.
Topics: Catalysis; Heterocyclic Compounds, 3-Ring; Humans; Janus Kinase 2; Ligands; Molecular Structure; Palladium; Protein Kinase Inhibitors | 2019 |